Trial
NCT00823342
ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Collaborators
Gilead Sciences; Pharmasset
Condition
HBe Negative Chronic Hepatitis B
Intervention
CLEVUDINE + TENOFOVIR PLACEBO
Why stopped
safety aspects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-06